U.S. Immigration and Customs Enforcement (ICE) has responded after a video shared widely on social media showed agents taking ...
Axsome Therapeutics has wrapped its hands around an epilepsy candidate from AstraZeneca through an acquisition of Avenue ...
Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the third ...
Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA Ī±2,3 receptor positive allosteric modulatorDeepens Axsomeās broad ...
In todayās Health Headlines, can treatment-resistant epilepsy improve over time? Are melatonin supplements bad for your heart? And what resources are available for people who rely on emergency rooms ...
Robot-guided neurosurgery in patients with epilepsy involves accurately mapping the skull to identify the entry points and target areas. A recent study compared the clinical utility of a contactless ...
Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the ...
"Our findings highlight the interconnectedness of heart and vascular health with brain health in middle-aged and older adults," the authors wrote. "The bidirectional associations we observed suggest ...
For the millions of people worldwide living with severe forms of epilepsy, some do not respond to medication and it can be ...
Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay ...
Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...
And they feel lucky. The waitlist for treatment is three months long and ever-growing, according to Shriti Patel, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback